Medicare Enrolled
Dr. David McGinnis, M.D.
Urology Physician · Bryn Mawr, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McGinnis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McGinnis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McGinnis
Dr. David McGinnis is an urology physician in Bryn Mawr, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. McGinnis performed 8,923 Medicare services across 3,899 unique beneficiaries.
Between the years covered by Open Payments, Dr. McGinnis received a total of $7,057 from 53 pharmaceutical and/or device companies across 279 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McGinnis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in PA
$7,057 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,923
Medicare services
Top 4% in PA for urology physician
3,899
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~470 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, degarelix, 1 mg | 3,120 | $3 | $10 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,419 | $3 | $13 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,099 | $97 | $290 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
866 | $9 | $112 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
475 | $51 | $141 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
448 | $67 | $211 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
373 | $8 | $12 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 264 | $134 | $826 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
227 | $11 | $166 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
79 | $67 | $424 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
69 | $27 | $103 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
49 | $72 | $265 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
49 | $137 | $418 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
46 | $109 | $603 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
42 | $42 | $101 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
35 | $84 | $273 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
34 | $147 | $398 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
34 | $221 | $284 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
30 | $27 | $455 |
| Wet mounts, including preparations of vaginal, cervical or skin specimens | 30 | $14 | $15 |
| Body fluid pH level test A laboratory test that measures the acidity or alkalinity of a body fluid sample. |
29 | $4 | $8 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
25 | $66 | $264 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
25 | $29 | $158 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
21 | $70 | $225 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
18 | $65 | $784 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
17 | $2,504 | $7,200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,057
Total received (2018-2024)
Avg $1,008/year across 7 years
Top 20% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
279
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,020 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,019
2023
$942
2022
$455
2021
$793
2020
$438
2019
$1,839
2018
$1,571
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$244
Janssen Scientific Affairs, LLC
$143
BIOPROTECT MEDICAL, INC.
$114
Astellas Pharma US Inc
$83
ABBVIE INC.
$75
PFIZER INC.
$70
PROGENICS PHARMACEUTICALS, INC.
$53
Novartis Pharmaceuticals Corporation
$50
Telix Pharmaceuticals
$40
AstraZeneca Pharmaceuticals LP
$34
Boston Scientific Corporation
$32
Merck Sharp & Dohme LLC
$25
Teleflex LLC
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
COLOPLAST CORP
$14
PROCEPT BioRobotics Corporation
$13
Top 3 companies account for 49.1% of 2024 payments
All-time payments by company (2018-2024) ›
Dendreon Pharmaceuticals LLC
$1,265
Astellas Pharma US Inc
$783
Janssen Biotech, Inc.
$744
KARL STORZ Endoscopy-America
$654
PFIZER INC.
$268
Boston Scientific Corporation
$247
Ferring Pharmaceuticals Inc.
$238
Endo Pharmaceuticals Inc.
$180
Amgen Inc.
$163
Coloplast Corp
$149
Janssen Scientific Affairs, LLC
$143
Medtronic, Inc.
$137
Avadel Specialty Pharmaceuticals, LLC
$130
Merck Sharp & Dohme LLC
$130
ABBVIE INC.
$124
BIOPROTECT MEDICAL, INC.
$114
BOSTON SCIENTIFIC CORPORATION
$112
Bayer HealthCare Pharmaceuticals Inc.
$109
TOLMAR Pharmaceuticals, Inc.
$109
AstraZeneca Pharmaceuticals LP
$94
Progenics Pharmaceuticals, Inc.
$82
Telix Pharmaceuticals
$80
BAXTER HEALTHCARE
$76
Teleflex LLC
$62
PROCEPT BioRobotics Corporation
$61
Mission Pharmacal Company
$60
UROVANT SCIENCES INC
$53
AbbVie, Inc.
$53
PROGENICS PHARMACEUTICALS, INC.
$53
Novartis Pharmaceuticals Corporation
$50
180 Medical, Inc.
$47
Tolmar, Inc.
$42
Blue Earth Diagnostics Limited
$42
Agiliti Surgical, Inc.
$32
Photocure Inc
$31
Allergan Inc.
$30
MEDIVATION FIELD SOLUTIONS LLC
$29
Baxter Healthcare
$24
Acerus Pharmaceuticals Corporation
$24
Myovant Sciences Inc.
$24
Accord Healthcare, Inc.
$22
KCI USA, Inc
$20
Sun Pharmaceutical Industries Inc.
$20
Sumitomo Pharma America, Inc.
$18
AbbVie Inc.
$17
Medtronic USA, Inc.
$16
Clovis Oncology, Inc.
$15
Bayer Healthcare Pharmaceuticals Inc.
$15
ACCORD HEALTHCARE, INC.
$15
C. R. Bard, Inc. & Subsidiaries
$14
COLOPLAST CORP
$14
Merck Sharp & Dohme Corporation
$13
Prometheus Laboratories Inc.
$11
Top 3 companies account for 39.6% of all-time payments
Associated products mentioned in payments ›
0.30MM · 16 FR. FLEXIBLE VIDEO CYSTOSCOPE · 16 FR. FLEXIBLE VIDEO CYSTOSCOPE · 22FR · 24/26 FR. · 30'AUTOCLAV · 4mm · 7 FR X 40CM · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Androgel · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BIPOLAR · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · CUTTING LOOP · CYSTO-URETHRO-FIBERSCOPE · CYSTOSCOPE-URETHROSCOPE SHEATH ONLY · CYSVIEW · Cysview · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLEX-XC CMOS URETEROSCOPE 8.5 FR X 675MM · FLEXIBLE · FLOSEAL · FORCEPS · GEMTESA · GENERAL ONCOLOGY · GENERAL UTERINE TISSUE REMOVAL · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · GENTLECATH · GRASPING · GREENLIGHT · GREENLIGHT HOPKINS II OPTIK 30 · GentleCath · HOPKINS · ILLUCCIX · IMFINZI · INTERSTIM · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LithoVue · Luja Coude · Lupron · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · PREVENA · PROVENGE · PYLARIFY · Proleukin · Prolia · REMICADE · Rezum Generator · SOLESTA · SPEEDICATH · SUTENT · SpaceOAR System · SpaceOAR VUE System - 10mL · TELESCOPE · TISSEEL · TITAN · UROLIFT · Uribel · UroLift System · Urocit-K · VESICARE · Veozah · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
306
Per 100K population
53.1
County median income
$88,576
Nearest hospital
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McGinnis is a clinical cardiology specialist, with above-average Medicare volume (top 4% in PA), with low-engagement industry engagement in the top 20% of PA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McGinnis experienced with injection, degarelix, 1 mg?
Based on Medicare claims data, Dr. McGinnis performed 3,120 injection, degarelix, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McGinnis receive payments from pharmaceutical companies?
Yes. Dr. McGinnis received a total of $7,057 from 53 companies across 279 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McGinnis's costs compare to other urology physicians in Bryn Mawr?
Dr. McGinnis's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McGinnis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Bryn Mawr
Browse urology physicians in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology